TLR7/8 stress response drives histiocytosis in SLC29A3 disorders.
Takuma ShibataRyota SatoMasato TaokaShin-Ichiroh SaitohMayumi KomineKiyoshi YamaguchiSusumu GoyamaYuji MotoiJiro KitauraKumi IzawaYoshio YamauchiYumiko TsukamotoTakeshi IchinoheEtsuko FujitaRyosuke HiranumaRyutaro FukuiYoichi FurukawaToshio KitamuraToshiyuki TakaiArinobu TojoMamitaro OhtsukiUmeharu OhtoToshiyuki ShimizuManabu OzawaNobuaki YoshidaToshiaki IsobeEicke LatzKojiro MukaiTomohiko TaguchiHiroaki HemmiShizuo AkiraKensuke MiyakePublished in: The Journal of experimental medicine (2023)
Loss-of-function mutations in the lysosomal nucleoside transporter SLC29A3 cause lysosomal nucleoside storage and histiocytosis: phagocyte accumulation in multiple organs. However, little is known about the mechanism by which lysosomal nucleoside storage drives histiocytosis. Herein, histiocytosis in Slc29a3-/- mice was shown to depend on Toll-like receptor 7 (TLR7), which senses a combination of nucleosides and oligoribonucleotides (ORNs). TLR7 increased phagocyte numbers by driving the proliferation of Ly6Chi immature monocytes and their maturation into Ly6Clow phagocytes in Slc29a3-/- mice. Downstream of TLR7, FcRγ and DAP10 were required for monocyte proliferation. Histiocytosis is accompanied by inflammation in SLC29A3 disorders. However, TLR7 in nucleoside-laden splenic monocytes failed to activate inflammatory responses. Enhanced production of proinflammatory cytokines was observed only after stimulation with ssRNAs, which would increase lysosomal ORNs. Patient-derived monocytes harboring the G208R SLC29A3 mutation showed enhanced survival and proliferation in a TLR8-antagonist-sensitive manner. These results demonstrated that TLR7/8 responses to lysosomal nucleoside stress drive SLC29A3 disorders.